𝔖 Bobbio Scriptorium
✦   LIBER   ✦

On Estimating Medical Cost and Incremental Cost-Effectiveness Ratios with Censored Data

✍ Scribed by Hongwei Zhao; Lili Tian

Book ID
110724960
Publisher
John Wiley and Sons
Year
2001
Tongue
English
Weight
679 KB
Volume
57
Category
Article
ISSN
0006-341X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Sample size and power issues in estimati
Sample size and power issues in estimating incremental cost-effectiveness ratios from clinical trials data
✍ Andrew R. Willan; Bernie J. O'Brien πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 98 KB πŸ‘ 2 views

It is becoming increasingly more common for a randomized controlled trial of a new therapy to include a prospective economic evaluation. The advantage of such trial-based cost-effectiveness is that conventional principles of statistical inference can be used to quantify uncertainty in the estimate o

A propensity score approach to estimatin
A propensity score approach to estimating the cost–effectiveness of medical therapies from observational data
✍ Nandita Mitra; Alka Indurkhya πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 143 KB

## Abstract Health summary measures are commonly used by policy makers to help make decisions on the allocation of societal resources for competing medical treatments. The net monetary benefit is a health summary measure that overcomes the statistical limitations of a popular measure namely, the co